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Abstract
Background: The responses of immunological factors to different subtypes of Kawasaki disease (KD) remain poorly
understood.
Methods: We recruited 388 patients with KD, 160 patients with infectious febrile disease and 85 normal children
who served as control subjects. Both the levels and percentages of T lymphocyte subsets, natural killer cells (NK
cells) and B cells were analyzed via flow cytometry. The levels of serum IgG, IgM, IgA and C3, C4 were assessed via
velocity scatter turbidimetry.
Results: The most significant differences noted between the patients with infectious febrile disease and the normal
children were the elevated levels of B cells, C3 and the ratio of CD4/CD8, and the decreased levels of CD8+ T cells
and NK cells, as well as the moderate increase in the absolute value of the CD3+ cells. The decreased T cell levels
and the elevated B cell levels were helpful in distinguishing typical KD from atypical KD; the elevated T cell levels,
the elevated NK cell and B cell levels and the decreased B cell levels were helpful in predicting the effectiveness of
IVIG; low C3 and C4 levels were linked with prodromal infections.
Conclusions: Lymphocytes subsets and complement markers may be useful in differentiating among the different
subtypes of KD and in helping clinicians understand the pathophysiology of KD.
Keywords: Kawasaki disease, Mucocutaneous lymph node syndrome, T lymphocyte subsets, Natural killer cells,
B lymphocytes, Immunoglobulin, Coronary artery lesion
Background
Kawasaki disease (KD), also known as mucocutaneous
lymph node syndrome, is an autoimmune vasculitis syn-
drome that occurs in children [1]. Both the prevalence and
the incidence of KD are much higher among East Asian
children compared with children living in the rest of the
world [2]. The primary pathological changes associated
with KD include systemic non-specific vasculitis involving
both small and medium-sized blood vessels, particularly the
coronary arteries, and the possible formation of coronary
artery aneurysms, which cause coronary narrowing and
thrombotic infarction, resulting in both myocardial infarc-
tion and sudden death [3]. KD may cause cardiac
complications among children and may increase an individ-
ual’s risk of ischemic heart disease during adulthood [4].
Although the pathogenesis of KD has not been fully elu-
cidated, infectious agents are postulated to be responsible
for the disease’s onset [5], as both the activation and the
dysfunction of the immune system are often observed dur-
ing the acute phase of the disease [6]. Based on the results
of recent research studies, it is possible that the immuno-
pathogenesis of KD is related to acute rheumatic fever. The
hypothetical pathogenesis underlying the development of
KD is as follows [7]: following an infection involving an un-
known KD pathogen, pathogenic substances produced as a
result of the infection spread and bind to the endothelial
cells of both small and medium-sized blood vessels. To con-
trol the actions of these pathogenic substances, the cells of
the immune system are activated. Initially, non-specific T
cells and non-specific antibodies are involved in this
* Correspondence: chinesemd@hotmail.com
†Equal contributors
3Department of Infectious Diseases, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan 430022, P.R. China
Full list of author information is available at the end of the article
© 2015 Ding et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ding et al. BMC Musculoskeletal Disorders  (2015) 16:315 
DOI 10.1186/s12891-015-0744-6
reaction; these hyperactivated immune cells produce various
types of cytokines, which results in a cytokine imbalance as-
sociated with further endothelial cell injury [7]. Following
the resolution of the inflammation involving the blood ves-
sels, specific T cells and antibodies are released against the
pathogenic proteins; tissue injury subsequently ceases, and a
repair process involving the immune cells begins [7].
Therefore, this hypothesis implies that the lymphocyte
levels in patients with KD may be different from those
observed in both normal control subjects and febrile pa-
tients and that the levels of these lymphocytes may vary
among the subtypes of KD. However, the mechanisms
underlying the changes involving the T cells, the B cells,
the natural killer cells and the immunoglobulins in pa-
tients with KD remain unclear; therefore, no accurate
diagnostic tests or laboratory tests that may help clini-
cians differentiate among the subtypes of KD have been
developed [6, 8–10]. It is necessary to determine the
mechanisms underlying the changes involving IgG, IgM
and IgA, C3 and C4 and T cells, B cells and NK cells in
the different types of KD to determine the possible role
that a particular diagnostic test may have in the setting
of KD. In this study, we performed a comparison of the
immunological response profiles of children with differ-
ent subtypes of KD.
Methods
Subjects
A total of 388 hospitalized patients with KD (262 boys
and 126 girls) between 2 months and 14 years of age were
recruited from Wuhan Children’s Hospital, Wuhan,
China, from August 2010 to April 2013. Each of the pa-
tients had been previously healthy, as their symptoms had
first manifested within 10 days of their being hospitalized.
Children receiving either hormone therapy or immuno-
suppressive therapy, children who had suffered from an
infectious disease that was diagnosed by a physician and
confirmed via laboratory testing within the previous
2 weeks, and children who suffered from another auto-
immune disease were not eligible for the study. All study
procedures conformed to the ethical standards established
by the Medical Ethics Committee of Wuhan Children’s
Hospital and were approved by the Commission. All study
protocols conformed to internationally accepted principles
and the guidelines of the Ethics Committee of Wuhan
Children’s Hospital. Informed consent was authorized by
the Medical Ethics Committee of Wuhan Children’s Hos-
pital. Consent was provided by the patient’s next of kin,
caretaker, or guardian. Each participant or individual act-
ing on their behalf provided written informed consent to
participate in this study.
Controls
The febrile control group included children enrolled
from August 2012 to April 2013. A total of 160 pa-
tients, including 104 males and 56 females between
2 months and 11 years of age, with an average age
of 2.43 ± 2.20 years, were included. The febrile con-
trols included children with febrile diseases caused
by respiratory tract infections, including pneumonia,
bronchopneumonia, and acute tonsillitis. The normal
control group was recruited from January to December,
2013. A total of 85 patients, including 54 males and
31 females between 4 months and 13.17 years of
age, with an average age of 2.49 ± 1.89 years, were re-
cruited. The normal controls included patients who pre-
sented for routine health examinations, circumcisions











388 2.30 years 32.47 % 54.0 % 96.13 % 25.78 % 93.81 %
Table 2 Demographic details
KD group Febrile control Normal control
subsets N Age N Age N Age
all cases 388 2.30 ± 1.99 160 2.43 ± 2.20 85 2.49 ± 1.89
male 262 2.25 ± 2.02 104 2.24 ± 2.09 54 2.23 ± 1.35
female 126 2.40 ± 1.93 56 2.79 ± 2.37 31 2.96 ± 2.53
prodromal infection 213 2.18 ± 2.02
no prodromal infection 175 2.44 ± 1.95
typical KD 373 2.29 ± 1.98
incomplete KD 15 2.56 ± 2.23
CAL 100 2.46 ± 2.17
Non-CAL 288 2.24 ± 1.93
IVIG sensitive 364 2.30 ± 1.94
IVIG nonresponsive 24 2.33 ± 2.71
Ding et al. BMC Musculoskeletal Disorders  (2015) 16:315 Page 2 of 9
or indirect inguinal hernias. No significant difference
was noted among the three groups regarding the chil-
dren’s ages. The age ratios of the male and female par-
ticipants in each of the control groups were not
significantly different.
The diagnostic criteria for KD
The diagnosis of KD was made using the criteria de-
fined by the American Heart Association [11, 12]. A
child was diagnosed with typical KD if he or she had
fever for 5 days or more, with at least 4 of the fol-
lowing 5 signs or symptoms: (1) acute changes in
the extremities, including erythema and edema of
the hands and feet and membranous desquamation
of the fingertips; (2) polymorphous exanthema;
(3) bilateral, painless bulbar conjunctivitis without
exudate; (4) changes in the lips and oral cavity, in-
cluding erythema and cracking of lips, a strawberry
tongue, and diffuse injection of the oral and
pharyngeal mucosa; and (5) cervical lymphadenop-
athy (≥1.5 cm in diameter), which is usually unilat-
eral [11, 12].
The diagnosis of incomplete KD
The diagnosis of incomplete KD was also made
using the criteria of the American Heart Association
[11, 12]. A child was diagnosed with incomplete KD
(or atypical KD) if he or she had fever for more than
5 days but had fewer than 4 of the 5 clinical mani-
festations mentioned above.
The diagnostic criteria of the coronary artery lesions
(CAL)
The CAL diagnostic criteria were also defined by the
American Heart Association [11, 12], as follows: (1) an
ultrasonic cardiograph (UCG) depicted enhancement of
the coronary endomembrane; (2) the normal coronary
artery diameter and aortic annulus (AoA) diameter ratio
for the left coronary artery (LCA)/AoA = 0.150 ± 0.020
(0.09 ~ 0.21) or the right coronary artery (RCA)/AoA =
0.130 ± 0.020 (0.09 ~ 0.20) occupied the aforementioned
ranges. This ratio was independent of age, gender,
height, weight and body surface area.
The criteria for a prodromal infection
The general tests for infectious diseases were performed
upon each patient’s visit to a physician, including the
IgM test for Chlamydia pneumoniae, Legionella pneu-
mophila serotype I, Rickettsia burneti, Influenza type A
and B, Parainfluenza, Adenovirus, Respiratory Syncytial
Virus, IgM and IgG, Early Antigen and Core Antigen for
Epstein-Barr Virus (EBV), IgM and IgG for Cytomegalo-
virus (CMV) and Mycoplasma pneumonia, the antistrep-
tolysin “o” test (ASO), and a blood culture for both
oxybiontic and anaerobic bacteria. If any of the above
tests was positive, a prodromal infection was considered.
The treatment of patients with KD
The IVIG treatment window occurred within 5 to
10 days following the onset of fever. The lyophilized hu-
man serum low pH intravenous gamma globulin was
produced by the Chengdu Institute of Biological
Table 3 Comparison of absolute value and percentage of lymphocyte subsets among KD, febrile and normal group
Group n CD3 CD4 CD8 CD16 CD56 CD19 CD4/CD8
KD group (count/μl) 388 2177.68 ± 1361.88**†† 1360.66 ± 914.86** 694.96 ± 492.43†† 312.14 ± 291.27†† 1218.80 ± 803.16**†
Febrile group (count/μl) 160 2680.22 ± 2105.36** 1496.28 ± 1179.19** 1068.54 ± 1220.52** 428.56 ± 430.11 1046.73 ± 863.80**
Normal group (count/μl) 85 1765.88 ± 656.00 890.09 ± 363.65 724.53 ± 299.90 369.38 ± 232.85 539.92 ± 257.89
KD group (%) 388 56.23 ± 10.50**†† 35.09 ± 9.28** 18.12 ± 6.50**†† 8.23 ± 5.47**†† 32.88 ± 11.27**†† 2.27 ±
1.13**††
Febrile group (%) 160 62.08 ± 11.30 34.70 ± 9.08** 24.07 ± 9.27** 10.18 ± 5.66** 25.27 ± 10.51** 1.63 ±
0.71**
Normal group (%) 85 64.09 ± 6.89 32.01 ± 4.66 26.46 ± 4.96 13.45 ± 5.96 19.75 ± 5.00 1.25 ± 0.30
Data were shown as mean ± SD. * p <0.05 compared to the normal group, ** p <0.01 compared to the normal group; † p <0.05 compared to the febrile group, ††
p <0.01 compared to the febrile group
Table 4 Comparison of immunoglobin and complements among KD, febrile and normal group
Group n IgG IgA IgM C3 C4
KD group (g/L) 388 7.13 ± 3.00†† 0.77 ± 0.49** 1.29 ± 0.64 1.28 ± 0.24**†† 0.27 ± 0.09††
Febrile group (g/L) 160 8.02 ± 2.93** 0.75 ± 0.58* 1.28 ± 0.53 1.14 ± 0.28** 0.30 ± 0.13*
Normal group (g/L) 85 7.21 ± 1.48 0.63 ± 0.34 1.15 ± 0.44 1.01 ± 0.21 0.28 ± 0.09
Data were shown as mean ± SD. * p <0.05 compared to the normal group, ** p <0.01 compared to the normal group; † p <0.05 compared to the febrile group, ††
p <0.01 compared to the febrile group
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Products at the Ministry of Health. A single intravenous in-
fusion of IVIG was given at a dose of 2 g/kg and combined
with aspirin therapy at a dose of 30 ~ 50 mg/(kg • d); these
treatments were divided into 3 to 4 doses for continuous
treatment until each patient’s symptoms disappeared, as in-
dicated by a normal level of C-reactive protein, a normal
platelet count, a normal white blood cell count, and a nor-
mal erythrocyte sedimentation rate, after two months had
passed. The course of treatment for concurrent CAL in-
cluded the prolonged administration of aspirin until each
patient’s coronary artery diameters returned to their normal
values. The patients suffering from concurrent CAL or
exhibiting PLT ≥ 500 × 109/L were simultaneously treated
with oral dipyridamole, 30 ~ 50 mg / (kg.d).
The criteria of both sensitive and non-reactive KD for
intravenous immunoglobulin (IVIG) therapy
After IVIG treatment was administered, the diagnosis of
non-reactive KD was confirmed if the patient’s fever (i.e.,
body temperature >38 °C) did not disappear within 48 h
of the most recent infusion [13]. If the fever resolved,
the patient’s KD was diagnosed as IVIG sensitive KD.
Specimen collection
Four milliliters of venous blood were split into a coagu-
lant tube and an EDTA-tube. Both the immunoglobulins
and the lymphocyte subsets were assayed within 8 h. All
specimens were collected before beginning IVIG
treatment.
Instruments and reagents
An FACS Calibur flow cytometry instrument equipped
with an argon ion laser with an excitation wavelength of
488 nm was manufactured by BD Biosciences. The im-
munoglobulin detector, a BN-II special protein analyzer,
was produced by Siemens. Philips IE33 color Doppler
echocardiography was used for the UCG examination,
and the probe was an S8-3 child-specific cardiac probe.
The CD4-APC, CD8-PE, CD3-FITC, CD19-APC,
CD16CD56-PE fluorescent antibody, hemolysin (10×)
and absolute count tubes (Trucount tube) were each
purchased from BD Biosciences.
Detection via flow cytometry
Approximately 50 μl of whole blood were aspirated into
a Trucount tube, and 20 μl of fluorescent antibody was
subsequently added. After 20 min, 450 μl of hemolysin
(1×) were added in the dark at room temperature and
allowed to remain at room temperature for 15 min be-
fore testing. The automatic software Multi TEST was
utilized to analyze the lymphocyte subsets.
Statistical analysis
The differences among three groups were compared via
ANVOA, and the differences between two groups were
compared using an independent samples t-test. SPSS
12.0 statistical software was utilized to complete the stat-




All 388 patients were recruited from Wuhan Children’s
Hospital. As shown in Table 1 and 2, the mean age of the
participants was 2.30 years (range: 0.17–14) old, and
32.47 % of the participants were girls. The majority of the
patients (n = 213, 54.0 %) suffered a prodromal infec-
tion. Three hundred and seventy-three patients
(96.13 %) were diagnosed with typical KD. One hun-
dred patients (25.78 %) were diagnosed with CAL,
and 364 patients (93.81 %) were responsive to IVIG
treatment. The incidence rate of KD was higher
among male patients than female patients, but the
age of onset was not different between the male and
female patients.
Table 5 Comparison of absolute value and percentage of lymphocyte subsets between typical and incomplete KD
Group n CD3 CD4 CD8 CD16 CD56 CD19 CD4/CD8
Typical KD (count/μl) 373 2144.26 ± 1355.17* 1341.05 ± 915.06* 683.15 ± 487.67* 306.75 ± 291.09 1220.17 ± 807.47 2.28 ± 1.15
Incomplete KD (count/μl) 15 3008.73 ± 1304.49 1848.13 ± 788.68 988.47 ± 536.45 446.07 ± 271.47 1184.80 ± 710.88 2.03 ± 0.71
Typical KD (%) 373 55.92 ± 10.49** 34.92 ± 9.36 17.99 ± 6.48 8.19 ± 5.53 33.27 ± 11.26**
Incomplete KD (%) 15 64.00 ± 7.41 39.33 ± 5.61 21.20 ± 6.54 9.27 ± 3.73 23.40 ± 6.41
Data were shown as mean ± SD. * p <0.05 compared to incomplete KD group, ** p <0.01 compared to incomplete KD group
Table 6 Comparison of immunoglobin and complements between typical and incomplete KD group
Group n IgG IgA IgM C3 C4
Typical KD (g/L) 373 7.12 ± 3.05 0.78 ± 0.50 1.29 ± 0.64 1.28 ± 0.25 0.27 ± 0.09
Incomplete KD (g/L) 15 7.39 ± 1.62 0.70 ± 0.35 1.29 ± 0.48 1.25 ± 0.23 0.29 ± 0.08
Data were shown as mean ± SD. * p < 0.05 compared to incomplete KD group, ** p < 0.01 compared to incomplete KD group
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A comparison of the lymphocyte subsets among the KD,
febrile and normal control groups
As shown in Table 3, the levels of CD3 cells noted the in
KD group were markedly lower than those noted in the
other two groups (p <0.01), whereas the absolute values
in both the KD and the Febrile group were higher than
that of that Normal group (p <0.01); the Febrile group
exhibited the largest elevation (p <0.01). Regarding the
CD4 cells, both the level and the absolute value were el-
evated in the KD group compared with the Normal
group (p <0.01); however, these parameters were not sig-
nificantly different from those of the Febrile group. Re-
garding the CD8 cells, the level noted in the KD group
was significantly lower than those of the other two
groups (p <0.01); however, the absolute value was de-
creased only in the Febrile group (p <0.01). The levels of
the CD16 and CD56 cells (NK cells) in both the KD and
the Febrile groups were significantly lower than those of
the Normal group; however, the levels noted in KD
group were the lowest of the three groups (p <0.01),
whereas the absolute values in both the KD and Normal
group were notably decreased compared with those of
the Febrile group (p <0.01). Regarding the B cells, both
the level and the absolute value of the CD19 cells in
both the KD and the Febrile groups were markedly ele-
vated compared with that of the Normal group (p <0.01);
the KD group demonstrated the most significant eleva-
tions of the two parameters (p <0.01 and p <0.05). The
results regarding the ratio of CD4/CD8 were the same
as those noted regarding the B cells (p <0.01).
A comparison of the immunoglobulins among the KD,
Febrile and normal control groups
As shown in Table 4, the level of IgG in the KD group
was significantly lower than that of the Febrile group
(p <0.01) but was not different than that of the Normal
group. The levels of IgA in both the KD group and the
Febrile group were higher than that of the Normal group
(p <0.05); however, the KD group’s level was more
significant (p <0.01), whereas the values of IgM among
the three groups were not significantly different. The
levels of C3 in both the KD and the Febrile groups were
much higher than that of the Normal group (p <0.01);
however, the KD group exhibited greater elevation com-
pared with the Febrile group (p <0.01). Regarding C4,
the KD group was not significantly different compared
with the Normal group, but the Febrile group exhibited
an elevated level compared with the other two groups, a
difference that was statistically significant (p <0.01 and p
<0.05).
A comparison of the lymphocyte subsets and the
immunoglobulins between the typical KD group and the
incomplete KD group
As shown in Table 5, compared with the incomplete
group, the absolute values of the CD3, CD4 and CD8
cells were significantly lower among the patients with
typical KD (p <0.05), whereas the percentage of the CD3
cells was lower, and the percentage of the CD19 cells
was markedly higher among these patients (p <0.01). As
shown in Table 6, there were no significant differences
in the levels of immunoglobulins and complement be-
tween the typical KD group and the incomplete KD
group.
A comparison of the lymphocyte subsets and the
immunoglobulins between the IVIG nonresponsive group
and the IVIG sensitive group
As shown in Table 7, compared with the IVIG nonre-
sponsive group, the absolute values of the CD3, CD4,
CD8, CD16CD56 and CD19 cells were significantly
higher among the patients in the IVIG sensitive group
(p <0.01 and p <0.05), and the percentages of the CD3,
CD4, CD8 and CD19 cells were markedly higher in this
group (p <0.01 and p <0.05). As shown in Table 8, the
levels of C3 were significantly higher among the patients
of the IVIG sensitive group (p <0.05).
Table 7 Comparison of absolute value and percentage of lymphocyte subsets between IVIG sensitive and nonresponsive group
Group n CD3 CD4 CD8 CD16 CD56 CD19 CD4/CD8
IVIG sensitive (count/μl) 364 2235.66 ± 1334.14** 1396.26 ± 906.23** 713.22 ± 480.79** 320.29 ± 287.96* 1240.26 ± 808.21* 2.25 ± 1.12
IVIG nonresponsive (count/μl) 24 1298.38 ± 1501.81 820.75 ± 892.87 417.92 ± 588.64 188.49 ± 319.00 893.38 ± 653.29 2.48 ± 1.29
IVIG sensitive (%) 364 56.80 ± 10.08** 35.39 ± 9.21* 18.34 ± 6.43** 8.37 ± 5.53 32.23 ± 10.75**
IVIG nonresponsive (%) 24 47.71 ± 13.04 30.50 ± 9.19 14.75 ± 6.73 6.18 ± 4.03 42.83 ± 14.25
Data were shown as mean ± SD. * p <0.05 compared to IVIG nonresponsive group, ** p <0.01 compared to IVIG nonresponsive group
Table 8 Comparison of immunoglobin andcomplements between IVIG sensitive and nonresponsive group
Group n IgG IgA IgM C3 C4
IVIG sensitive (g/L) 364 7.11 ± 2.86 0.77 ± 0.48 1.28 ± 0.54 1.29 ± 0.24* 0.27 ± 0.09
IVIG nonresponsive (g/L) 24 7.50 ± 4.79 0.76 ± 0.61 1.47 ± 1.48 1.14 ± 0.28 0.24 ± 0.08
Data were shown as mean ± SD. * p <0.05 compared to IVIG nonresponsive group, ** p <0.01 compared to IVIG nonresponsive group
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A comparison of the lymphocyte subsets and the
immunoglobulins between the CAL group and the non-
CAL group
As shown in Tables 9 and 10, there were no differences
in the levels of either the lymphocyte subsets or the im-
munoglobulins between the CAL group and the non-
CAL group.
A comparison of the lymphocyte subsets and the
immunoglobulins between the infection group and the
non-infection group
As shown in Tables 11 and 12, compared with the non-
infection group, the levels of C3 and C4 were signifi-
cantly higher in the infection group (p <0.01).
Discussion
Kawasaki disease was first described in Japan in 1967
and is most common among children in Asian and Pa-
cific Island countries, although it affects children of all
ethnicities and races. To date, making an accurate diag-
nosis remains critical in managing KD; however, the eti-
ology of KD is unknown, and no accurate diagnostic
tests or laboratory tests have been developed [14].
Therefore it is necessary to analyze clinical data as a
means of developing a diagnostic test for KD. In our
study, we analyzed 388 patients with KD, as well as 160
patients with febrile disease and 85 normal control sub-
jects, to analyze the differences in the absolute values
and the percentages of the lymphocyte subsets, immu-
noglobulins and complement types. The data indicated
that no differences existed among the three groups re-
garding the patients’ ages, nor were any differences re-
garding male and female gender noted among the
groups.
The results of this study indicate that the immune sta-
tuses of the patients with KD patients were abnormal
and that differences in the amounts of specific types of
immune cells were noted when compared with either
the normal or the febrile control subjects. With the on-
set of either KD or another febrile disease, both the ab-
solute values and the levels of the CD4+ cells were
elevated, which suggested that the helper T cells were
activated in response to elevated body temperatures. Re-
garding the CD8+ cells, the febrile group exhibited a
greater degree of elevation; however, the patients with
KD exhibited the opposite trend, which indicated that
the changes in the levels of the CD8+ cells may repre-
sent a distinction between the KD group and the febrile
group. Furthermore, the ratio of CD4/CD8 was signifi-
cantly different among the patients with KD, the infec-
tious febrile patients and the normal children. By
contrast, the CD16 and CD56+ cells (NK cells) in KD
group exhibited decreased levels, particularly where the
percentages of the NK cells were concerned. The CD19+
cells (B cells) were another distinguishing feature of the
patients with KD. When the body temperature in-
creased, the percentages and absolutes value of the B
cells became elevated in the patients with KD compared
with the patients in the infectious febrile group, which
demonstrated that elevated B cell levels may be a char-
acteristic used to distinguish these patients from both
normal and infectious febrile patients.
We also investigated changes in the levels of the im-
munoglobulins and the complement types among the
patients with KD. The results indicated that the level of
IgG was significantly higher in the infectious febrile
group compared with the other groups; however, the
level of IgM was not characterized by the same pattern,
which demonstrated that elevated IgG levels were char-
acteristic of infectious febrile diseases. Regarding the
levels of IgA, both the KD group and the febrile group
exhibited markedly elevated levels compared with the
normal group; however, there was no significant differ-
ence between the KD group and the Febrile group,
which implied that the levels of IgA may rise both in the
setting of KD and in the setting of infectious febrile dis-
eases, and may therefore not be a distinctive marker of
either pathology. Regarding the complement types, the
level of C4 followed the same trend as did IgG. By con-
trast, the level of C3 was significantly elevated among
the patients with KD patients, more so than among the
patients in the infectious febrile group, which demon-
strated that the C3 levels may be a parameter used to
distinguish KD from other diseases.
The results of these comparisons suggested that the
most typical differences between the patients with KD
and both the normal children and the infectious febrile
patients were the levels of the B cells, C3 and ratio of
CD4+ to CD8+ cells. The percentages of the CD8+ T
cells and the NK cells were also indicative of differences
Table 9 Comparison of absolute value and percentage of lymphocyte subsets between CAL and non-CAL group
Group n CD3 CD4 CD8 CD16 CD56 CD19 CD4/CD8
CAL (count/μl) 100 2067.04 ± 1369.82 1296.81 ± 903.35 630.54 ± 481.71 269.18 ± 243.26 1239.31 ± 896.90 2.40 ± 1.35
Non-CAL (count/μl) 288 2216.10 ± 1359.39 1382.83 ± 919.34 717.32 ± 494.96 327.05 ± 305.16 1211.68 ± 769.50 2.22 ± 1.05
CAL (%) 100 55.42 ± 11.00 34.86 ± 8.99 17.21 ± 6.80 7.45 ± 4.57 34.50 ± 12.95
Non-CAL (%) 288 56.52 ± 10.32 35.17 ± 9.39 18.43 ± 6.37 8.50 ± 5.73 32.32 ± 10.59
Data were shown as mean ± SD. * p <0.05 compared to non-CAL group, ** p <0.01 compared to non-CAL group
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among the groups, but this relationship did not apply to
their absolute values. The levels of the CD3+ T cells
were also significantly different among the three groups,
but the absolute value of the CD3+ cells in infectious fe-
brile group was much higher than that of the normal
group, whereas the percentage was not significantly dif-
ferent from that of the normal group. These results im-
plied that the focus of future KD research may involve B
cells, C3, and the CD4/CD8 ratio, as well as the percent-
ages of CD8+ T cells and NK cells; the absolute value of
CD3+ cells may also be useful in defining appropriate
diagnostic and laboratory tests for KD.
The pathogenesis of KD remains unknown. Previous
research has suggested that several single nucleotide
polymorphisms may associated with a genetic suscepti-
bility to KD, including functional polymorphisms of the
FC gamma RIIa locus and the ITPKC gene [15]. The
ITPKC gene is a T-cell activity modulator, which sug-
gests that T cell activity regulation may be an underlying
mechanism affecting both an individual’s predisposition
to developing KD and the severity of the disease’s course
[6]. Our research indicated that the absolute value of the
CD3+ cells and the ratio of CD4 to CD8 are distinguish-
ing features of patients with KD. However, the genes en-
coding B cells and C3 may also be associated with the
pathogenesis of KD.
Recent studies have determined that the predomina-
tion of IgA plasma cells within mucosal surfaces is a
common characteristic of many of the infectious dis-
eases of childhood, as well as KD [8, 16, 17], which sug-
gests that an immune response in a genetically
susceptible patient following exposure to a pathogen
represents the primary pathogenesis of KD. However, no
studies have confirmed this hypothesis [18]. Our re-
search determined that among patients with KD, the
levels of the B cells and C3 were both elevated compared
with those of normal children and patients with infec-
tious febrile diseases, which demonstrated that infection
may be only a trigger for the development of KD and
that the primary pathogenesis of the disease may involve
the immune system. The elevated B cell levels and ele-
vated C3 levels may indicate that the humoral immune
response predominates in patients with KD and that the
combination of a lack of cellular immunity and an ele-
vated complement level causes the disease.
We compared the levels of the lymphocyte subsets
and the complement types between patients with typical
KD and patients with incomplete KD, patients who were
IVIG nonresponsive and patients who were IVIG sensi-
tive, CAL and non-CAL subgroups and patients who ex-
perienced a prodromal infection and patients who did
not experience infection to identify more clinical fea-
tures with which to differentiate between these
subgroups.
Incomplete KD describes patients with an incomplete
presentation of the disease, irrespective of the presence
of coronary complications, who do not fulfill the clas-
sical diagnostic criteria for KD. Comparisons of
complete blood counts, albumin levels, hepatic transam-
inases, and acute phase reactants between the children
with typical KD and the children with incomplete KD
yielded no significant differences; however, low levels of
serum alanine aminotransferase and gamma glutamyl-
transferase, as well as low frequencies of hyponatremia
and pyuria, were reported among the patients with in-
complete presentations [19]. However, distinguishing in-
complete KD from typical KD remains tied to patients’
clinical presentations as opposed to their laboratory
values. Therefore, we compared the lymphocyte subsets,
immunoglobulins and complement types between the
patients with incomplete KD and the patients with typ-
ical KD to find candidates for the laboratory-based dif-
ferentiation of the subsets of KD. The absolute values of
the CD3+, CD4+ and CD8+ T cells were much lower in
the typical KD group, which implied that T cell-
mediated immune reactions do not predominate in the
setting of typical KD. B cell-mediated immune reactions
appear to be the primary mechanisms underlying the
Table 10 Comparison of immunoglobin and complements between CAL and non-CAL group
Group n IgG IgA IgM C3 C4
CAL (g/L) 100 7.40 ± 3.25 0.80 ± 0.48 1.43 ± 0.91 1.27 ± 0.25 0.26 ± 0.08
Non-CAL (g/L) 288 7.04 ± 2.91 0.76 ± 0.49 1.24 ± 0.50 1.29 ± 0.24 0.28 ± 0.09
Data were shown as mean ± SD. * p <0.05 compared to non-CAL group, ** p <0.01 compared to non-CAL group
Table 11 Comparison of absolute value and percentage of lymphocyte subsets between infection and non-infection group
Group n CD3 CD4 CD8 CD16 CD56 CD19 CD4/CD8
Infection (count/μl) 213 2220.21 ± 1453.05 1407.65 ± 980.84 706.04 ± 520.13 290.24 ± 273.03 1231.98 ± 831.04 2.29 ± 1.13
Non-infection (count/μl) 175 2125.92 ± 1244.10 1303.46 ± 826.67 681.47 ± 457.58 338.78 ± 310.76 1202.77 ± 769.93 2.24 ± 1.13
Infection (%) 213 56.39 ± 10.60 35.38 ± 9.33 18.05 ± 6.42 7.92 ± 5.72 33.15 ± 11.49
Non-infection (%) 175 56.05 ± 10.40 34.74 ± 9.23 18.20 ± 6.61 8.60 ± 5.15 32.56 ± 11.01
Data were shown as mean ± SD. * p <0.05 compared to non-infection group, ** p <0.01 compared to non-infection group
Ding et al. BMC Musculoskeletal Disorders  (2015) 16:315 Page 7 of 9
pathogenesis of KD, as the percentage of CD19+ cells
was markedly elevated in the typical KD group. These
data demonstrate that the low expression levels of T
cells and the high expression levels of B cells may be as-
sociated with typical KD. Recent studies have focused on
the regulation of T-cell activation as a critical factor in
determining an individual’s susceptibility to Kawasaki
disease, as well as the severity of an individual’s disease
[6]. However, incomplete KD is characterized by a higher
T-cell level, which implies that T cell dysregulation plays
a role in this disease. It also represents a means with
which to differentiate incomplete KD from typical KD.
The treatment for KD is IVIG plus aspirin within
10 days of the onset of symptoms to reduce the risk of
coronary artery complications [20]. Therefore, we used
IVIG with aspirin to treat KD and attempted to deter-
mine if there were any differences between the IVIG
sensitive group and the IVIG nonresponsive group. In
the IVIG sensitive group, the levels of each of the T cell
subgroups, the B cells and the NK cells, but not the ratio
of CD4/CD8, were significantly higher than those of the
IVIG nonresponsive group, which demonstrates that the
immunological responses in the body were activated.
Likewise, the percentages of the CD3+, CD4+ and CD8+
cells were significantly increased, and the percentage of
the CD19+ cells was significantly decreased in the IVIG
sensitive group, which implied that in the IVIG sensitive
group, the T-cell-mediated immune responses predomi-
nated. Therefore, we can deduce that with increases in
the levels of T cells, KD will be more sensitive to IVIG
treatment, regardless of the parameters’ absolute values
or percentages. There have not been any reports regard-
ing the specific characteristics of KD patients that may
make them more likely to be sensitive to IVIG. Our re-
search may help in the identification of markers that are
predictive of IVIG sensitivity. Additionally, IVIG resist-
ant KD may be associated with other processes, as op-
posed to only T-cell-mediated immunological reactions.
KD is a type of systemic vasculitis syndrome that pri-
marily invades the medium-sized muscular arteries, par-
ticularly the coronary arteries. Coronary arteritis results
in the immediate inflammation of each of the arterial
layers following the onset of KD; the inflammation sub-
sequently spreads throughout the artery [5]. We ana-
lyzed the lymphocyte subsets and the immunoglobulins
between the CAL and the non-CAL group. There were
no differences between the groups, which implied that
how to predict onset of arteritis may be associated with
another type of indication.
Although the underlying mechanism of KD is un-
known, epidemiological data suggest that the disease is
inked with the increased activation of the immune sys-
tem in response to infection [14, 21]. However, the exact
mechanism is unknown. In this study, we compared the
lymphocyte subsets and the immunoglobulins between
the patients who suffered a prodromal infection and the
patients who did not suffer an infection. The results
demonstrated that only the levels of C3 and C4 were
lower in the infection group than in the non-infection
group. C3 and C4 are the most commonly measured
complement components and help the body’s immune
system to react to both inflammation and infection. De-
creased complement levels are often associated with an
increased risk of developing autoimmune diseases or de-
veloping recurrent microbial infections [22]. Therefore,
the patients with KD who suffered from prodromal in-
fections may also have suffered from autoimmune reac-
tions. Further investigation of this issue is warranted.
For this study, we recruited 388 patients with KD, as
well as 160 infectious febrile patients and 85 normal
children who served as control subjects, to explore the
differences among these groups’ lymphocyte subsets, im-
munoglobulins and complement types. The results indi-
cated that the differences that distinguished the patients
with KD from the infectious febrile patients and the nor-
mal children pertained to the B cells, C3 and the ratio of
CD4/CD8, as well as the percentages of CD8+ T cells
and NK cells and the absolute value of the CD3+ cells.
We also compared the profiles of both the lymphocyte
subsets and the immunoglobulins between the patients
with typical KD and the patients with incomplete KD,
and the patients in the IVIG sensitive group and the pa-
tients in the IVIG nonresponsive group, the CAL and
the non-CAL group, and the patients who suffered a
prodromal infection and the patients who did not suffer
an infection. These comparisons provided evidence that
decreased T cell levels and elevated B cell levels distin-
guished typical KD from incomplete KD and that ele-
vated T cell levels, NK cell levels and B cell levels, as
well as decreased B cell percentages, may be helpful in
predicting IVIG effectiveness, whereas low C3 and C4
levels may be associated with prodromal infections.
Lymphocyte subsets and complement types may be
markers with which to differentiate KD from other
Table 12 Comparison of immunoglobin andcomplements between infection and non-infection group
Group n IgG IgA IgM C3 C4
Infection (g/L) 213 7.01 ± 3.20 0.75 ± 0.50 1.27 ± 0.53 1.25 ± 0.23** 0.26 ± 0.08**
Non-infection (g/L) 175 7.28 ± 2.75 0.80 ± 0.48 1.32 ± 0.74 1.32 ± 0.26 0.29 ± 0.09
Data were shown as mean ± SD. * p <0.05 compared to non-infection group, ** p <0.01 compared to non-infection group
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infectious febrile diseases and from normal children, and
may also be helpful in distinguishing between typical KD
and incomplete KD, IVIG sensitivity and IVIG unre-
sponsiveness and patients with prodromal infections and
those without prodromal infections. These findings may
help to guide the diagnosis of KD and to assist in the
differentiation of KD from other diseases, as well as to
understand the underlying pathophysiology of the
various subtypes of KD.
Conclusions
Lymphocytes subsets and complements might be some
markers for differentiating KD from other infectious
febrile diseases and normal children, and also helpful to
distingush incomplete KD, IVIG nonresponse and pro-
dromal infection of KD from the status of typical KD,
IVIG sensitive and no prodromal infection. These find-
ings shall help to guide diagnosis and differentiation of
KD and understand disease pathophysiology of various
subtypes of KD.
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